White Lauren 4
4 · C4 Therapeutics, Inc. · Filed Jun 21, 2021
Insider Transaction Report
Form 4
White Lauren
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-06-21+136,000→ 136,000 totalExercise: $38.49Exp: 2031-06-20→ Common Stock (136,000 underlying)
Footnotes (1)
- [F1]25% of this option shall vest and become exercisable on June 21, 2022, with the remainder vesting in 36 equal monthly installments thereafter.